Seeing Is Believing

Currently out of the existing stock ratings of Max Masucci, 11 are a HOLD (13.1%), 73 are a BUY (86.9%).
Analyst Max Masucci, carries an average stock price target met ratio of 48.68% that have a potential upside of 21.18% achieved within 164 days. Previously, Max Masucci worked at TD COWEN, CANACCORD.
Max Masucci’s has documented 157 price targets and ratings displayed on 24 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on CTKB, Cytek Biosciences at 08-Nov-2023.
Analyst best performing recommendations are on QTRX (QUANTERIX CORP).
The best stock recommendation documented was for QTRX (QUANTERIX CORP) at 10/6/2020. The price target of $40 was fulfilled within 1 day with a profit of $3.1 (8.4%) receiving and performance score of 84.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Aug-2021
$35
$8.03 (29.77%)
$27
1 months 3 days ago
(10-Aug-2026)
8/9 (88.89%)
$10.14 (40.79%)
321
Hold Since 18-Nov-2021
$4400
4 years 4 months 1 days ago
(12-May-2022)
1/3 (33.33%)
$4270.8 (3305.57%)
38
Buy Since 02-Feb-2021
$620
4 years 4 months 24 days ago
(20-Apr-2022)
0/2 (0%)
$145.4 (30.64%)
$17
$3.87 (29.47%)
4 years 9 months 20 days ago
(24-Nov-2021)
2/2 (100%)
$-117.6 (-87.37%)
790